LIMA1 and neoplasm: Collectively, these findings delineate a novel oncogenic axis wherein BPNT1 scaffolds STUB1-mediated ubiquitination and degradation of LIMA1, driving EMT-facilitated tumor progression and DTX chemoresistance (Fig. 7I).